All news from Anaesthesiology

Violence In The Emergency Department

Emergency departments are becoming increasingly violent places as doctors bear the brunt of the fallout from the opioid epidemic. Nearly seven in 10 of survey respondents said ER violence has increased over the past five years, with one-quarter reporting it has increased greatly.

Nearly half of American emergency physicians said they have been physically assaulted at work, and three in five report those assaults happened during the past year, according to a new poll commissioned by the American College of Emergency Physicians (ACEP).

Infectious Bacteria at High Rates, Vampire Bats Found to be Carriers

Bartonella are bacteria that cause endocarditis, a potentially life-threatening illness in humans and domestic animals. In Latin America, common vampire bats (Desmodus rotundus) are frequently infected by Bartonella, and their subsistence on blood creates a risk for bacterial transmission from bats to humans and livestock.

A study published in PLOS Neglected Tropical Diseases by Daniel Becker at Montana State University in Bozemandistributed found Bartonella infections in vampire bats are highly prevalent in Peru and Belize, and that Bartonella genotypes are distributed widely, rather than clustered geographically.

T Cell Bispecific Antibody For Breast Cancer cells

Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Todayowever, novel immunotherapeutics across different tumor types, either as monotherapy or in combination, are increasingly becoming one of the most innovative and powerful anti-cancer strategies.

Industry-funded Clinical Trials: Funder Involved in all Aspects

In most industry-funded trials reported in high impact medical journals, all aspects of the trial involved the industry funder, finds a study published by The BMJ. The results show that, although both funder and academic authors were involved in the design, conduct, and reporting of most trials, few industry-funded trials were completely independently conducted by academics, and sometimes industry involvement was downplayed or omitted.